- Home
- Publications
- Publication Search
- Publication Details
Title
Antiretroviral Treatment 2010: Progress and Controversies
Authors
Keywords
-
Journal
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
Volume 55, Issue -, Pages S43-S48
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2010-11-02
DOI
10.1097/qai.0b013e3181f9c09e
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Once-Daily Atazanavir/Ritonavir Compared With Twice-Daily Lopinavir/Ritonavir, Each in Combination With Tenofovir and Emtricitabine, for Management of Antiretroviral-Naive HIV-1-Infected Patients: 96-Week Efficacy and Safety Results of the CASTLE Study
- (2010) Jean-Michel Molina et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Antiretroviral Treatment of Adult HIV Infection
- (2010) Melanie A. Thompson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis
- (2010) Monika Müller et al. LANCET INFECTIOUS DISEASES
- Early versus Standard Antiretroviral Therapy for HIV-Infected Adults in Haiti
- (2010) Patrice Severe et al. NEW ENGLAND JOURNAL OF MEDICINE
- The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy
- (2009) Mina C Hosseinipour et al. AIDS
- Once-daily darunavir/ritonavir vs. lopinavir/ritonavir in treatment-naive, HIV-1-infected patients: 96-week analysis
- (2009) Anthony M Mills et al. AIDS
- Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials
- (2009) Christine Katlama et al. AIDS
- High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment‐Experienced Patients Infected with Multidrug‐Resistant HIV: Results of the ANRS 139 TRIO Trial
- (2009) Y. Yazdanpanah et al. CLINICAL INFECTIOUS DISEASES
- Incidence of Non-AIDS-Defining Malignancies in HIV-Infected Versus Noninfected Patients in the HAART Era: Impact of Immunosuppression
- (2009) Roger J Bedimo et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Raltegravir, Etravirine, and Ritonavir-Boosted Darunavir: A Safe and Successful Rescue Regimen for Multidrug-Resistant HIV-1 Infection
- (2009) Arkaitz Imaz et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Life Expectancy After HIV Diagnosis Based on National HIV Surveillance Data From 25 States, United States
- (2009) Kathleen McDavid Harrison et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Interleukin-2 Therapy in Patients with HIV Infection
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
- (2009) Mari M. Kitahata et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of patients with the immune reconstitution inflammatory syndrome
- (2009) Suzaan Marais et al. Current HIV/AIDS Reports
- The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients
- (2008) Joel E Gallant et al. AIDS
- Safety, Pharmacokinetics, and Antiretroviral Activity of Multiple Doses of Ibalizumab (formerly TNX-355), an Anti-CD4 Monoclonal Antibody, in Human Immunodeficiency Virus Type 1-Infected Adults
- (2008) J. M. Jacobson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetic properties and tolerability of bevirimat and atazanavir in healthy volunteers: An open-label, parallel-group study
- (2008) David E. Martin et al. CLINICAL THERAPEUTICS
- British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008
- (2008) BG Gazzard et al. HIV MEDICINE
- Changes in the Risk of Death After HIV Seroconversion Compared With Mortality in the General Population
- (2008) Krishnan Bhaskaran JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Major Clinical Outcomes in Antiretroviral Therapy (ART)–Naive Participants and in Those Not Receiving ART at Baseline in the SMART Study
- (2008) JOURNAL OF INFECTIOUS DISEASES
- Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection
- (2008) Gerd Fätkenheuer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection
- (2008) David A. Cooper et al. NEW ENGLAND JOURNAL OF MEDICINE
- Maraviroc for Previously Treated Patients with R5 HIV-1 Infection
- (2008) Roy M. Gulick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection
- (2008) Roy T. Steigbigel et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now